EUVIMEDOpdag EUVIMED
Crossref

Scutellarein alleviates osteoarthritis progression through the PI3K /Akt/ NF‐kappaB signaling pathway: In vitro and in vivo studies

Ziyang Ye, Zhihan Ge, Shu Yang, Ting Hu, Qiong Ye, Hui Chen iD

Phytotherapy Research · 2024-07 · 38 (7) · 3509-3524

DOI: 10.1002/ptr.8232 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2024-05-02. Written by Ziyang Ye and 5 co-authors. Institution: Department of Orthopedics, Wenzhou Central Hospital, Wenzhou, China. Major MEDLINE topics: Osteoarthritis, NF-kappa B, Proto-Oncogene Proteins c-akt, Signal Transduction. Cited 9 times so far (Crossref); 47 references. Funded by: Science and Technology Plan Project of Wenzhou Municipality.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Osteoarthritis (OA), a joint disease that is associated with inflammatory processes is involved in joint destruction. Scutellarein (Scu), a component of the medicinal herbs Scutellaria barbata D. Don and Erigeron breviscapus (vant) Hand Mass , has anti‐inflammatory effects. We explored the role of Scu in the development of OA and the underlying mechanisms. CCK‐8 assays, Calcein‐AM/PI and EdU staining were used to determine chondrocyte viability after Scu exposure. Western blot, qPCR, as well as ELISA were utilized to measure extracellular matrix (ECM) degradation and inflammation. Immunofluorescence (IF), western blot and luciferase assays were used to examine the NF‐kappaB (NF‐κB) pathway. Scu interacting proteins were predicted using network pharmacology analysis and molecular docking. X‐ray, H&E, Safranin O‐Fast Green(S‐O), toluidine blue, and immunohistochemistry analysis were used to examine the therapeutic effects of Scu in OA using destabilization of medial meniscus (DMM) models. Scu demonstrated inhibitory effects on ECM degradation and pro‐inflammatory factor levels in chondrocytes treated with IL‐1β. Mechanistically, Scu inhibited the IL‐1β‐induced activation of the PI3K/Akt/ NF‐κB signaling pathway cascades. Furthermore, Scu has been shown to have significant binding capacities to PI3K. Additionally, Scu ameliorated the OA progression in DMM models. Our findings suggest that Scu may contribute to the amelioration of OA progression by targeting the PI3K/Akt/NF‐κB signaling pathway, implying Scu possesses promising therapeutic potential for the treatment of OA.

Subjects

MeSH terms (MEDLINE)

OsteoarthritisNF-kappa BProto-Oncogene Proteins c-aktSignal TransductionPhosphatidylinositol 3-KinasesChondrocytesApigeninAnimalsMaleMolecular Docking SimulationRats, Sprague-DawleyAnti-Inflammatory AgentsRatsHumansExtracellular Matrix

Author keywords

NF‐κBPI3K/AktScutellareininflammationosteoarthritis

Substances

NF-kappa BProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesApigeninscutellareinAnti-Inflammatory Agents

Authors and institutions

  • Department of Orthopedics, Wenzhou Central Hospital, Wenzhou, China.
  • Department of Orthopedics, The Second Affiliated Hospital of Shanghai University, Wenzhou, China.
  • Department of Rehabilitation, Wenzhou People's Hospital, Wenzhou, China.
  • Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

ORCID profiles: Hui Chen

Funding

  • Science and Technology Plan Project of Wenzhou Municipality

Cite

APA

Ye, Z., Ge, Z., Yang, S., Hu, T., Ye, Q., & Chen, H. (2024). Scutellarein alleviates osteoarthritis progression through the PI3K /Akt/ NF‐kappaB signaling pathway: In vitro and in vivo studies. Phytotherapy Research, 38(7), 3509-3524. https://doi.org/10.1002/ptr.8232

Vancouver

Ye Z, Ge Z, Yang S, Hu T, Ye Q, Chen H. Scutellarein alleviates osteoarthritis progression through the PI3K /Akt/ NF‐kappaB signaling pathway: In vitro and in vivo studies. Phytotherapy Research. 2024;38(7):3509-3524. doi:10.1002/ptr.8232

BibTeX
@article{Ye2024,
  author = {Ye, Ziyang and Ge, Zhihan and Yang, Shu and Hu, Ting and Ye, Qiong and Chen, Hui},
  title = {Scutellarein alleviates osteoarthritis progression through the PI3K /Akt/ NF‐kappaB signaling pathway: In vitro and in vivo studies},
  journal = {Phytotherapy Research},
  year = {2024},
  volume = {38},
  number = {7},
  pages = {3509--3524},
  doi = {10.1002/ptr.8232}
}
Start for free →